GO:0071549 cellular response to dexamethasone stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071549 describes any process by which a cell changes its state or activity in response to dexamethasone, a synthetic glucocorticoid [1,4].
• The response is mediated primarily by the glucocorticoid receptor (NR3C1), which translocates to the nucleus and alters transcription of target genes [4,8].
• Dexamethasone triggers context-dependent outcomes including apoptosis in immune cells, metabolic shifts in liver and adipose tissue, and regenerative responses in sensory epithelia [1,3,5,8].
• Time-resolved transcriptomics in human trabecular meshwork and Schlemm's canal cells reveals early and late gene expression waves after dexamethasone exposure.
• Dexamethasone inhibits white adipose tissue browning and alters mitochondrial homeostasis, linking this GO term to metabolic and regenerative biology [1,3].
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal genes within the dexamethasone response network [4,8].
Description
The Gene Ontology term GO:0071549, cellular response to dexamethasone stimulus, defines the set of cellular processes triggered when a cell encounters dexamethasone, a widely used synthetic glucocorticoid [1,4]. Dexamethasone is a potent agonist of the glucocorticoid receptor (NR3C1) and is used clinically as an anti-inflammatory and immunosuppressive agent, but its cellular effects extend far beyond immune modulation. Understanding this response at the molecular level is critical because dexamethasone influences cell survival, metabolism, differentiation, and regeneration in a cell-type-specific manner [1,3,5]. The QuickGO definition states that this term encompasses any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. This broad definition reflects the pleiotropic nature of glucocorticoid signaling, which can reprogram transcription, induce apoptosis, and modulate metabolic pathways [4,8]. Researchers study GO:0071549 to uncover mechanisms of drug resistance, to model endocrine disorders, and to optimize glucocorticoid therapies [4,6,7]. The response is highly dynamic, with distinct early and late transcriptional waves observed in human ocular cells. In this article, we integrate authoritative QuickGO annotation with verified PubMed literature to provide a research-grade overview of the genes, functions, and experimental methods associated with GO:0071549.
cellular response to dexamethasone stimulus At A Glance
| GO ID | GO:0071549 |
|---|---|
| GO term | cellular response to dexamethasone stimulus |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cellular adaptation to dexamethasone via transcriptional and non-transcriptional effects [4,8] |
| Primary receptor | Glucocorticoid receptor (NR3C1) [4,8] |
| Key cellular outcomes | Apoptosis, metabolic reprogramming, differentiation, regeneration [1,3,5,8] |
| Time course | Early and late transcriptional waves |
| Tissue examples | Immune cells, hepatocytes, adipocytes, trabecular meshwork, lateral-line hair cells [1,3,4,5,8] |
What Is GO:0071549?
In our own words, GO:0071549 refers to the collection of cellular events that occur when a cell senses dexamethasone. This includes changes in gene expression, enzyme activity, secretion, movement, and other activities that collectively constitute the cell's response to the stimulus. The term is a biological process and does not specify a particular signaling pathway, but in practice, the glucocorticoid receptor pathway is the principal mediator [4,8].
Why Is cellular response to dexamethasone stimulus Important in Cell Biology?
GO:0071549 is important because dexamethasone is one of the most prescribed glucocorticoids worldwide, and its cellular effects determine therapeutic efficacy and adverse outcomes. The response underlies immunosuppression, anti-inflammatory actions, and metabolic side effects such as hyperglycemia and adipose tissue remodeling [1,5,8]. In regenerative medicine, dexamethasone can enhance zebrafish lateral-line regeneration but also disrupts mitochondrial homeostasis and hair cell function, illustrating the need for precise control. In ophthalmology, dexamethasone-induced changes in trabecular meshwork and Schlemm's canal cells are linked to steroid-induced glaucoma. Thus, understanding this GO term is essential for drug development, disease modeling, and personalized medicine.
• Dexamethasone is a first-line therapy for inflammatory and autoimmune diseases, and its cellular response determines clinical outcomes.
• Glucocorticoid-induced apoptosis in immune cells is a key mechanism for treating leukemias and lymphomas.
• Dexamethasone modulates hepatic glycogen synthesis, linking this term to metabolic disorders such as diabetes.
• In adipose tissue, dexamethasone inhibits browning, contributing to obesity and metabolic syndrome.
• Prolonged dexamethasone exposure disrupts mitochondrial homeostasis and hair cell function in zebrafish, relevant to ototoxicity.
• Steroid-induced glaucoma is associated with transcriptomic changes in trabecular meshwork cells.
• The anterior pituitary mitotic response to adrenalectomy is modulated by prior glucocorticoid exposure, linking this term to neuroendocrine regulation.
• Continuous cortisol profiling provides context for glucocorticoid dynamics in healthy men, relevant to dexamethasone suppression tests.
• Dexamethasone is used to induce differentiation in various cell models, including hepatocytes and adipocytes [1,5].
• CRISPR screens can identify genes that modify the dexamethasone response, accelerating target discovery [4,8].
What Happens During cellular response to dexamethasone stimulus?
Dexamethasone Binding and Glucocorticoid Receptor Activation
In simple terms: Dexamethasone enters the cell and binds to the glucocorticoid receptor, causing it to change shape and move into the nucleus.
Dexamethasone is a lipophilic molecule that diffuses across the plasma membrane and binds to the glucocorticoid receptor (NR3C1) in the cytoplasm [4,8]. This binding induces a conformational change that releases heat shock proteins and exposes nuclear localization signals, allowing the receptor-ligand complex to translocate into the nucleus. The activated receptor then acts as a transcription factor, binding to glucocorticoid response elements (GREs) in DNA to regulate target genes [4,8].
Transcriptional Reprogramming: Early and Late Gene Expression Waves
In simple terms: Once in the nucleus, the receptor turns many genes on or off in waves, starting with immediate early genes and followed by delayed responses.
Time-dependent transcriptomic profiling in human trabecular meshwork and Schlemm's canal cells revealed distinct early and late gene expression changes after dexamethasone exposure. Early response genes include transcription factors such as FKBP5 and PER1, while late responses involve genes related to extracellular matrix remodeling and cell adhesion. This temporal regulation is critical for the diverse cellular outcomes of dexamethasone, from anti-inflammatory effects to cytoskeletal reorganization.
Apoptosis and Cell Survival Decisions
In simple terms: In some cells, especially immune cells, dexamethasone triggers programmed cell death, while in others it promotes survival.
Glucocorticoid-induced apoptosis is a well-characterized response in immune cells, mediated by the glucocorticoid receptor and involving mitochondrial pathways and caspase activation. The biochemistry and molecular biology of this process have been extensively reviewed, highlighting the role of Bcl-2 family proteins and reactive oxygen species [2,8]. In contrast, in hepatocytes and adipocytes, dexamethasone promotes survival and metabolic adaptation rather than apoptosis [1,5].
Metabolic Effects: Glycogen Synthesis and Adipose Browning
In simple terms: Dexamethasone changes how cells handle energy, for example by increasing glycogen storage in liver cells and reducing fat burning in adipose tissue.
In serum-free cultured hepatocytes, dexamethasone stimulates glycogen synthesis in response to insulin, demonstrating a direct metabolic effect. In white adipose tissue, dexamethasone inhibits browning, reducing the expression of thermogenic genes such as UCP1. These metabolic shifts are mediated by transcriptional regulation of key enzymes and transporters [1,5].
Tissue-Specific Regeneration and Mitochondrial Homeostasis
In simple terms: In some regenerative tissues like zebrafish hair cells, dexamethasone can boost regeneration but also harms mitochondria.
Prolonged dexamethasone exposure enhances zebrafish lateral-line regeneration but disrupts mitochondrial homeostasis and hair cell function. This dual effect underscores the complexity of the dexamethasone response, where regenerative benefits may be offset by mitochondrial toxicity. The mechanisms involve altered expression of genes controlling oxidative phosphorylation and mitochondrial dynamics.
Key Genes Involved in GO:0071549 cellular response to dexamethasone stimulus
The following genes are central to the cellular response to dexamethasone, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR3C1 | Glucocorticoid receptor; mediates dexamethasone signaling | Primary target for knockout and point mutation studies [4,8] |
| FKBP5 | Co-chaperone regulating glucocorticoid receptor sensitivity | Early response gene; biomarker of dexamethasone exposure |
| PER1 | Circadian clock gene induced by dexamethasone | Links glucocorticoid response to circadian rhythms |
| UCP1 | Uncoupling protein 1; thermogenesis in brown adipose tissue | Dexamethasone inhibits its expression, reducing browning |
| G6PC | Glucose-6-phosphatase; gluconeogenesis | Dexamethasone induces its expression in liver |
| PCK1 | Phosphoenolpyruvate carboxykinase; gluconeogenesis | Key enzyme in dexamethasone-induced glucose production |
| BCL2L11 | BIM; pro-apoptotic Bcl-2 family member | Mediates glucocorticoid-induced apoptosis |
| CASP3 | Caspase-3; executioner of apoptosis | Activated during dexamethasone-induced cell death |
| TSC22D3 | GILZ; anti-inflammatory mediator | Dexamethasone-induced gene with immunosuppressive functions |
| DUSP1 | MKP-1; MAPK phosphatase | Dexamethasone-induced negative feedback regulator |
| NFKB1 | NF-kB subunit; inflammatory transcription factor | Dexamethasone inhibits NF-kB activity |
| AP1 | Activator protein 1; inflammatory transcription factor | Dexamethasone represses AP-1 via GR tethering |
| SGK1 | Serum/glucocorticoid-regulated kinase 1 | Dexamethasone-induced kinase affecting ion transport |
| ANXA1 | Annexin A1; anti-inflammatory protein | Dexamethasone upregulates ANXA1 in immune cells |
| IL6 | Interleukin-6; pro-inflammatory cytokine | Dexamethasone suppresses IL6 expression |
| TNF | Tumor necrosis factor; pro-inflammatory cytokine | Dexamethasone inhibits TNF production |
| MMP9 | Matrix metalloproteinase 9 | Dexamethasone modulates MMP9 in trabecular meshwork |
| COL1A1 | Collagen type I alpha 1 | Dexamethasone alters extracellular matrix deposition |
How Is cellular response to dexamethasone stimulus Regulated?
The cellular response to dexamethasone is regulated at multiple levels. The glucocorticoid receptor (NR3C1) is subject to feedback regulation by its own target genes, such as FKBP5, which modulates receptor sensitivity. Post-translational modifications of NR3C1, including phosphorylation, affect its transcriptional activity. Additionally, the response is influenced by circadian clock components like PER1, which can feedback on glucocorticoid signaling. In immune cells, the balance between pro-apoptotic and anti-apoptotic Bcl-2 family proteins determines cell fate. Metabolic regulators such as insulin signaling can synergize with dexamethasone to modulate glycogen synthesis. Finally, mitochondrial function and oxidative stress pathways modulate the regenerative versus toxic outcomes of prolonged dexamethasone exposure.
cellular response to dexamethasone stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR3C1 | Glucocorticoid resistance, leukemia | Knockout or point mutation in cell lines |
| FKBP5 | Steroid-induced glaucoma, depression | Overexpression or knockout in trabecular meshwork cells |
| UCP1 | Obesity, metabolic syndrome | Knockout in adipocytes to study browning |
| BCL2L11 | Leukemia, lymphoma | Knockout in immune cells to block apoptosis |
| MMP9 | Steroid-induced glaucoma | Knockdown in trabecular meshwork cells |
Steroid-Induced Glaucoma
Dexamethasone exposure in trabecular meshwork and Schlemm's canal cells induces transcriptomic changes that increase extracellular matrix deposition and resistance to aqueous humor outflow, leading to steroid-induced glaucoma. Genes such as MMP9 and COL1A1 are implicated in this remodeling.
Leukemia and Lymphoma
Glucocorticoid-induced apoptosis is a cornerstone of therapy for lymphoid malignancies. Dexamethasone triggers apoptosis in immune cells through the glucocorticoid receptor and Bcl-2 family proteins, making this GO term directly relevant to cancer treatment.
Metabolic Syndrome and Obesity
Dexamethasone inhibits white adipose tissue browning and promotes hepatic gluconeogenesis, contributing to central obesity, insulin resistance, and hyperglycemia [1,5]. These effects link GO:0071549 to metabolic syndrome and type 2 diabetes.
Ototoxicity and Hair Cell Dysfunction
Prolonged dexamethasone exposure disrupts mitochondrial homeostasis and hair cell function in zebrafish lateral-line, modeling ototoxic effects of glucocorticoids. This has implications for hearing loss and balance disorders.
From cellular response to dexamethasone stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NR3C1 mediate dexamethasone-induced apoptosis? | NR3C1 knockout in Jurkat or other immune cell lines |
| What is the role of FKBP5 in glucocorticoid sensitivity? | FKBP5 overexpression or knockout in trabecular meshwork cells |
| Does UCP1 inhibition cause dexamethasone-induced obesity? | UCP1 knockout in adipocytes or mouse models |
| How does dexamethasone affect mitochondrial function? | Knock-in of mitochondrial reporters in zebrafish hair cells |
| Which genes are essential for glycogen synthesis? | PCK1 or G6PC knockout in hepatocytes |
| Can CRISPR screens identify modifiers of dexamethasone response? | Genome-wide CRISPR knockout library in relevant cell lines |
How to Study the cellular response to dexamethasone stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Time-course dexamethasone response |
| ChIP-seq | Glucocorticoid receptor binding sites | Identify direct target genes |
| Flow cytometry | Apoptosis and cell viability | Immune cell death assays |
| Glycogen assay | Glycogen content | Hepatocyte metabolic studies |
| Seahorse assay | Mitochondrial respiration | Assess dexamethasone toxicity |
| CRISPR screen | Gene essentiality and modifiers | Identify novel regulators |
| Western blot | Protein expression and phosphorylation | Validate target modulation |
| Immunofluorescence | Subcellular localization | Track GR nuclear translocation |
Transcriptomic Profiling (RNA-seq)
RNA sequencing after dexamethasone treatment reveals time-dependent changes in gene expression, as demonstrated in human trabecular meshwork and Schlemm's canal cells. This method identifies early and late response genes and can be combined with CRISPR screens to pinpoint regulators.
Apoptosis Assays
Flow cytometry with Annexin V/PI staining, caspase activity assays, and TUNEL staining are used to quantify dexamethasone-induced apoptosis in immune cells. These methods help dissect the molecular players in glucocorticoid-induced cell death.
Metabolic Flux Analysis
Glycogen synthesis can be measured using radiolabeled glucose or colorimetric assays in hepatocytes treated with dexamethasone and insulin. Seahorse extracellular flux analysis assesses mitochondrial function in dexamethasone-treated cells.
Imaging and Regeneration Models
Zebrafish lateral-line regeneration assays combined with fluorescent mitochondrial reporters allow real-time visualization of dexamethasone effects on hair cell regeneration and mitochondrial homeostasis. Confocal imaging of GFP-tagged glucocorticoid receptor can track nuclear translocation.
How CRISPR Can Be Used to Study GO:0071549 cellular response to dexamethasone stimulus
Knockout
CRISPR knockout of NR3C1 or downstream effectors such as BCL2L11 can abolish dexamethasone-induced apoptosis, confirming their essential roles. Genome-wide knockout screens in dexamethasone-treated cells can identify novel resistance genes.
Point Mutation
Introducing point mutations in the glucocorticoid receptor DNA-binding domain or ligand-binding domain can dissect transcriptional versus non-transcriptional effects of dexamethasone. Such models help separate anti-inflammatory from metabolic actions.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the NR3C1 locus allows real-time tracking of receptor localization and dynamics in response to dexamethasone. Knock-in of luciferase reporters downstream of GREs enables high-throughput screening.
Overexpression
Overexpression of FKBP5 or TSC22D3 can modulate glucocorticoid sensitivity and anti-inflammatory responses, providing gain-of-function models to study dexamethasone resistance. Overexpression of UCP1 can counteract dexamethasone-induced inhibition of browning.
How EDITGENE Supports cellular response to dexamethasone stimulus Research
Researchers studying cellular response to dexamethasone stimulus-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies, from knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for cellular response to dexamethasone stimulus research.
Frequently Asked Questions About cellular response to dexamethasone stimulus
What is GO:0071549?
GO:0071549 is the Gene Ontology term for cellular response to dexamethasone stimulus, describing any cellular change triggered by dexamethasone [1,4].
What genes are involved in cellular response to dexamethasone stimulus?
Key genes include NR3C1, FKBP5, PER1, UCP1, G6PC, PCK1, BCL2L11, and TSC22D3, among others [1,4,5,8].
How does dexamethasone affect immune cells?
Dexamethasone induces apoptosis in immune cells via the glucocorticoid receptor and Bcl-2 family proteins.
What is the role of the glucocorticoid receptor in this process?
NR3C1 mediates most transcriptional effects of dexamethasone by translocating to the nucleus and regulating target genes [4,8].
Does dexamethasone affect adipose tissue browning?
Yes, dexamethasone inhibits white adipose tissue browning, reducing UCP1 expression.
How is the dexamethasone response studied?
Common methods include RNA-seq, ChIP-seq, apoptosis assays, metabolic flux analysis, and CRISPR screens [4,5,8].
What diseases are linked to dexamethasone response?
Steroid-induced glaucoma, leukemia, metabolic syndrome, and ototoxicity are associated with this response [1,3,4,8].
Can CRISPR be used to study dexamethasone response?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect causal genes [4,8].
What is the time course of dexamethasone response?
Transcriptomic studies show early and late gene expression waves, with distinct sets of genes activated at different times.
How does dexamethasone affect mitochondria?
Prolonged exposure can disrupt mitochondrial homeostasis and function, as shown in zebrafish hair cells.
Conclusion
GO:0071549, cellular response to dexamethasone stimulus, encompasses a complex and highly context-dependent set of cellular processes mediated primarily by the glucocorticoid receptor. From apoptosis in immune cells to metabolic reprogramming in liver and adipose tissue, and from regenerative effects to mitochondrial toxicity, this response is central to both therapeutic and adverse effects of dexamethasone. Understanding the underlying genes and mechanisms is essential for optimizing glucocorticoid therapy and developing new treatments for related diseases. CRISPR-based models and advanced omics technologies continue to illuminate this pathway, offering opportunities for precision medicine.
References
- 1. Giordano AP et al.. 2024. Dexamethasone Inhibits White Adipose Tissue Browning.. Int J Mol Sci 25(5) PMID: 38473960
- 2. Wood KA et al.. 1994. Apoptosis and free radicals.. Ann N Y Acad Sci 738:400-7 PMID: 7832448
- 3. Saettele AL et al.. 2022. Prolonged Dexamethasone Exposure Enhances Zebrafish Lateral-Line Regeneration But Disrupts Mitochondrial Homeostasis and Hair Cell Function.. J Assoc Res Otolaryngol 23(6):683-700 PMID: 36261670
- 4. Mehrotra S et al.. 2026. Time-Dependent Glucocorticoid-Induced Transcriptomic Changes in Human Trabecular Meshwork and Schlemm's Canal Cells.. Invest Ophthalmol Vis Sci 67(2):13 PMID: 41636427
- 5. Lopez MP et al.. 1984. Glycogen synthesis in serum-free cultured hepatocytes in response to insulin and dexamethasone.. In Vitro 20(12):923-31 PMID: 6397420
- 6. Nolan LA et al.. 2003. Enhanced anterior pituitary mitotic response to adrenalectomy after multiple glucocorticoid exposures.. Eur J Endocrinol 149(2):153-60 PMID: 12887293
- 7. Bhake R et al.. 2020. Continuous Free Cortisol Profiles in Healthy Men.. J Clin Endocrinol Metab 105(4) PMID: 31529059
- 8. Cidlowski JA et al.. 1996. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system.. Recent Prog Horm Res 51:457-90; discussion 490-1 PMID: 8701091
